Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia 3Sezary Syndrome 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Immunoblastic Lymphadenopathy 2Waldenstrom Macroglobulinemia 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Large Granular Lymphocytic 1

Interventions

Sunitinib 2MK 2206 2Hu-Mik-beta-1 monoclonal antibody 2Cyclosporine 2Carboplatin 2tipifarnib 1sargramostim 1nelarabine 1cediranib 1Vorinostat 1Therapeutics 1Psychiatric Rehabilitation 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Oxaliplatin 1Microarray Analysis 1MLN 8237 1Levofloxacin 1Lenalidomide 1Ketamine 1Interleukin-12 Subunit p35 1Interferon-alpha 1Imatinib Mesylate 1Ifosfamide 1Gene Expression Profiling 1Etoposide 1Docetaxel 1Dexamethasone 1Decitabine 1Dasatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Leukemia, Large Granular Lymphocytic × nelarabine × Clear all
NCT00003635 2013-07-18

506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents

National Cancer Institute (NCI)

Phase 2 Completed
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Large Granular Lymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡